SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (560)4/12/2005 10:49:20 AM
From: nigel bates  Read Replies (1) of 625
 
Humira sales for the quarter -

 Quarter Ended 3/31/05
    (dollars in millions)
                               Percent            Percent           Percent
                        U.S.   Change    Rest of  Change    Global  Change
                       Sales  vs. 1Q04    World  vs. 1Q04   Sales   vs. 1Q04

    HUMIRA              $164      61.0    $118    150.7      $282     89.4


"...Abbott continues to forecast 2005 worldwide sales for HUMIRA of more than $1.3 billion."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News